Effect Of Abhaya Vataka In The Management Of Fatty Liver Disease.

A Clinical Trial To Evaluate The Efficacy Of Abhaya Vataka In The Management Of Non Alcoholic Fatty Liver Disease. - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/069931

Enrollment

Registered

2024-07-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects, diagnosed with NAFLD according to the USG report, standard criteria accepted by the American Gastroenterology Association. Subjects diagnosed with Grade I & II Non Alcoholic Fatty liver Disease Subjects between the age of 18 and 60 years Subjects irrespective of gender and socio-economic status. Subjects who are willing to sign the consent form and agreeing to follow the protocol of the study.

Exclusion criteria

Exclusion criteria: 1) Subjects with history of alcohol intake more than 20 g/ day for women and more than 30g/day for men 2) Diagnosed case of renal, respiratory, cardiovascular (including IHD), neurologic diseases, Hepatocellular carcinoma, and liver cirrhosis. 3) Subjects with history of following drug intake -steroids, synthetic estrogens, heparin, and amiodarone, valproic acid, antiviral agents. 4) Pregnant women, lactating mothers and mentally challenged persons. 5) Uncontrolled Diabetes Mellitus and Hypertension.

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Abhaya Vataka in the management of NAFLD by using USG grading, LFT(excluding GGT) and subjective parameters. Timepoint: Subjective parameters: A dull or aching pain in the right quadrant of the abdomen Appetite Anorexia Fatigue Subjective parameters will be assessed on base line, 2 weeks, 5 weeks, 7 weeks, 9 weeks Objective parameters: USG Grading as per American Gastroenterology Association LFT(excluding GGT) Objective parameters will be assessed on base line and 9 weeks	—

Measure

Time frame

To evaluate the effect of Abhaya Vataka in the management of NAFLD by using USG grading, LFT(excluding GGT) and subjective parameters. Timepoint: Subjective parameters: A dull or aching pain in the right quadrant of the abdomen Appetite Anorexia Fatigue Subjective parameters will be assessed on base line, 2 weeks, 5 weeks, 7 weeks, 9 weeks Objective parameters: USG Grading as per American Gastroenterology Association LFT(excluding GGT) Objective parameters will be assessed on base line and 9 weeks

—

Secondary

Measure	Time frame
To assess the safety of Abhaya Vataka in subjects diagnosed with Non Alcoholic Fatty Liver Disease.Timepoint: Blood Routine with Erythrocyte sedimentation Rate Liver Function Test & Renal Function Test will be assessed on base line & 9 weeks.	—

Countries

India

Contacts

Public ContactRini R

Pankajakasthuri Ayurveda Medical College and PG Centre

rinisuraj911@gmail.com9605505588

Outcome results